Heterodimeric prodrug nanoassembly overcomes chemoresistance and ignites immunotherapy in glioblastoma
Chemical Engineering Journal · 2026-07 · 540 · 176873
DOI: 10.1016/j.cej.2026.176873 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemical Engineering Journal, 2026-07. Verfasst von Guanting Li und 12 weiteren Autor:innen. Die Arbeit nennt 60 Literaturangaben. Gefördert von: National Natural Science Foundation of China, China Postdoctoral Science Foundation, Fujian Medical University.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
- Fujian Medical University
Zitieren
APA
Li, G., Zheng, S., Wei, P., Li, H., Lu, M., Niu, X., Li, J., Wang, H., Huang, W., Ding, C., Lin, Y., Zhu, Y., & Kang, D. (2026). Heterodimeric prodrug nanoassembly overcomes chemoresistance and ignites immunotherapy in glioblastoma. Chemical Engineering Journal, 540, 176873. https://doi.org/10.1016/j.cej.2026.176873
Vancouver
Li G, Zheng S, Wei P, Li H, Lu M, Niu X, et al. Heterodimeric prodrug nanoassembly overcomes chemoresistance and ignites immunotherapy in glioblastoma. Chemical Engineering Journal. 2026;540:176873. doi:10.1016/j.cej.2026.176873
BibTeX
@article{Li2026,
author = {Li, Guanting and Zheng, Shunzhe and Wei, Penghui and Li, Haonan and Lu, Meixiu and Niu, Xuegang and Li, Jiebo and Wang, Huimin and Huang, Wen and Ding, Chenyu and Lin, Yuanxiang and Zhu, Yang and Kang, Dezhi},
title = {Heterodimeric prodrug nanoassembly overcomes chemoresistance and ignites immunotherapy in glioblastoma},
journal = {Chemical Engineering Journal},
year = {2026},
volume = {540},
pages = {176873},
doi = {10.1016/j.cej.2026.176873}
}
EUVIMED